Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × camrelizumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 9 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Uterine Cervical Neoplasms 2 Nasopharyngeal Carcinoma 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Cervical Cancer Metastatic 2 Carcinoma, Non-Small-Cell Lung 2 Adenocarcinoma 2 Triple Negative Breast Neoplasms 1 Salivary Gland Neoplasms 1 Recurrence 1 Pancreatic Neoplasms 1 Non-squamous Non-small-cell Lung Cancer 1 Mouth Neoplasms 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer 1 Leukemia, Myeloid, Acute 1 Laryngeal Neoplasms 1 Gestational Trophoblastic Disease 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Squamour Cell Cancer 1 Endometrioid Endometrial Cancer 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Advanced Gastric Cancer 1

Interventions

Cyclophosphamide 21 Cytarabine 13 venetoclax 12 Vincristine 12 Dexamethasone 12 Methotrexate 10 Etoposide 9 Doxorubicin 9 prednylidene 8 deltacortene 8 Prednisone 8 merphos 7 dexamethasone acetate 7 dexamethasone 21-phosphate 7 auricularum 7 Calcium Dobesilate 7 fludarabine phosphate 6 pegaspargase 5 fludarabine 5 azathiopurine 5 Stem Cell Transplantation 5 Specimen Handling 5 Sirolimus 5 Mercaptopurine 5 Leucovorin 5 Granulocyte Colony-Stimulating Factor 5 Filgrastim 5 Azacitidine 5 Whole-Body Irradiation 4 Rituximab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡